Highly multiplexed genotyping of thiopurine S-methyltransferase variants using MALDI-TOF mass spectrometry: reliable genotype in different ethnic groups
| dc.contributor.author | Asante-Poku, S. | |
| dc.contributor.author | Elke Schaeffeler, E. | |
| dc.contributor.author | Ulrich, M. | |
| dc.contributor.author | Zanger, S. | |
| dc.contributor.author | Jae-Gook, S. | |
| dc.contributor.author | Schwab, M. | |
| dc.date.accessioned | 2012-05-02T10:53:22Z | |
| dc.date.accessioned | 2017-10-19T11:59:48Z | |
| dc.date.available | 2012-05-02T10:53:22Z | |
| dc.date.available | 2017-10-19T11:59:48Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | To avoid severe hematotoxicity in patients, determination of the TPMT (thiopurine S-methyltransferase) genotype before commencing thiopurine therapy has become accepted. | en_US |
| dc.identifier.uri | http://197.255.68.203/handle/123456789/885 | |
| dc.language.iso | en | en_US |
| dc.publisher | Clinical Chemistry (54): 1637-1647 | en_US |
| dc.title | Highly multiplexed genotyping of thiopurine S-methyltransferase variants using MALDI-TOF mass spectrometry: reliable genotype in different ethnic groups | en_US |
| dc.type | Article | en_US |